Papatheodoridi M. Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative Chronic Hepatitis B patients: Results from the DARING-B prospective Greek study. PS-159.
Effectiviteit en beschikbaarheid van hiv-geneesmiddelen bij kinderen
nov 2022 | HIV, Virale infecties